The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
Open accessAbstract
OBJECTIVE: To assess the clinical effectiveness and cost-effectiveness of photodynamic diagnosis (PDD) compared with white light cystoscopy (WLC), and urine biomarkers [fluorescence in situ hybridisation (FISH), ImmunoCyt, NMP22] and cytology for the detection and follow-up of bladder cancer. DATA SOURCES: Major electronic databases including MEDLINE, MEDLINE In-Process, EMBASE, BIOSIS, Science Citation Index, Health Management Information Consortium and the Cochrane Controlled Trials Register were searched until April 2008. REVIEW METHODS: A systematic review of the literature was carried out according to standard methods. An economic model was constructed to assess the cost-effectiveness of alternative diagnostic and follow-up strategies for the diagnosis and management of patients with bladder cancer. RESULTS: In total, 27 studies reported PDD test performance. In pooled estimates [95% confidence interval (CI)] for patient-level analysis, PDD had higher sensitivity than WLC [92% (80% to 100%) versus 71% (49% to 93%)] but lower specificity [57% (36% to 79%) versus 72% (47% to 96%)]. Similar results were found for biopsy-level analysis. The median sensitivities (range) of PDD and WLC for detecting lower risk, less aggressive tumours were similar for patient-level detection [92% (20% to 95%) versus 95% (8% to 100%)], but sensitivity was higher for PDD than for WLC for biopsy-level detection [96% (88% to 100%) versus 88% (74% to 100%)]. For more aggressive, higher-risk tumours the median sensitivity of PDD for both patient-level [89% (6% to 100%)] and biopsy-level [99% (54% to 100%)] detection was higher than those of WLC [56% (0% to 100%) and 67% (0% to 100%) respectively]. Four RCTs comparing PDD with WLC reported effectiveness outcomes. PDD use at transurethral resection of bladder tumour resulted in fewer residual tumours at check cystoscopy [relative risk, RR, 0.37 (95% CI 0.20 to 0.69)] and longer recurrence-free survival [RR 1.37 (95% CI 1.18 to 1.59)] compared with WLC. In 71 studies reporting the performance of biomarkers and cytology in detecting bladder cancer, sensitivity (95% CI) was highest for ImmunoCyt [84% (77% to 91%)] and lowest for cytology [44% (38% to 51%)], whereas specificity was highest for cytology [96% (94% to 98%)] and lowest for ImmunoCyt [75% (68% to 83%)]. In the cost-effectiveness analysis the most effective strategy in terms of true positive cases (44) and life-years (11.66) [flexible cystoscopy (CSC) and ImmunoCyt followed by PDD in initial diagnosis and CSC followed by WLC in follow-up] had an incremental cost per life-year of over 270,000 pounds. The least effective strategy [cytology followed by WLC in initial diagnosis (average cost over 20 years 1403 pounds, average life expectancy 11.59)] was most likely to be considered cost-effective when society's willingness to pay was less than 20,000 pounds per life-year. No strategy was cost-effective more than 50% of the time, but four of the eight strategies in the probabilistic sensitivity analysis (three involving a biomarker or PDD) were each associated with a 20% chance of being considered cost-effective. In sensitivity analyses the results were most sensitive to the pretest probability of disease (5% in the base case). CONCLUSIONS: The advantages of PDD's higher sensitivity in detecting bladder cancer have to be weighed against the disadvantages of a higher false-positive rate. Taking into account the assumptions made in the model, strategies involving biomarkers and/or PDD provide additional benefits at a cost that society might be willing to pay. Strategies replacing WLC with PDD provide more life-years but it is unclear whether they are worth the extra cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Qualitative research in health care: Analysing qualitative data
Pope, C. (2000) · BMJ · doi:10.1136/bmj.320.7227.114 · Cited by 8,131
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A.-C., Boyd, S., Skinner, E., Bochner, B., Thangathurai, D., Mikhail, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.666 · Cited by 3,530
Sylvester, R. J., van der Meijden, A. P. M., Oosterlinck, W., Witjes, J. A., Bouffioux, C., Denis, L., Newling, D. W. W., & Kurth, K. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.031 · Cited by 3,013
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Sampling in qualitative research. Purposeful and theoretical sampling: Merging or clear boundaries?
Coyne, I. T. (1997) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1997.t01-25-00999.x · Cited by 2,402
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,379
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
von der Maase, H., Sengelov, L., Roberts, J. T., Ricci, S., Dogliotti, L., Oliver, T., Moore, M. J., Zimmermann, A., & Arning, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.757 · Cited by 1,850
Evaluating patient-based outcome measures for use in clinical trials.
Fitzpatrick, Davey, Buxton, & Jones (1998) · Health Technology Assessment · doi:10.3310/hta2140 · Cited by 1,715
A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations
Rutter, C. M., & Gatsonis, C. A. (2001) · Statistics in Medicine · doi:10.1002/sim.942 · Cited by 1,505
Qualitative research methods in health technology assessment: a review of the literature.
Murphy, Dingwall, Greatbatch, Parker, & Watson (1998) · Health Technology Assessment · doi:10.3310/hta2160 · Cited by 1,107
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Kirkali, Z., Chan, T., Manoharan, M., Algaba, F., Busch, C., Cheng, L., Kiemeney, L., Kriegmair, M., Montironi, R., Murphy, W. M., et al. (2005) · Urology · doi:10.1016/j.urology.2005.07.062 · Cited by 1,074
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041
Self-citationWilkinson, E. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-70 · Cited by 929
Superficial Bladder Cancer: Progression and Recurrence
Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., Hawkins, I. R., & For National Bladder Cancer Collaborative Group A S002253471751695X-1bb6d6502e02ba4ea1210f9f5bd6022d George R. Prout The principal investigators and institutions that contributed to the study are, M. G. H. (1983) · Journal of Urology · doi:10.1016/s0022-5347(17)51695-x · Cited by 924
Quality-of-life measures in chronic diseases of childhood
Eiser, C., & Morse, R. (2001) · Health Technology Assessment · doi:10.3310/hta5040 · Cited by 872
The health economics of bladder cancer: A comprehensive review of the published literature
Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., & Hauser, R. (2003) · PharmacoEconomics · doi:10.1007/bf03262330 · Cited by 860
García-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D. W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67137-1 · Cited by 627
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
van Rhijn, B. W. G., van der Poel, H. G., & van der Kwast, T. H. (2005) · European Urology · doi:10.1016/j.eururo.2005.03.014 · Cited by 530
Moher, D., Pham, B., Lawson, M., & Klassen, T. (2003) · Health Technology Assessment · doi:10.3310/hta7410 · Cited by 500
Lotan, Y., & Roehrborn, C. G. (2003) · Urology · doi:10.1016/s0090-4295(02)02136-2 · Cited by 474
Oosterlinck, W., Lobel, B., Jakse, G., Malmström, P.-U., Stöckle, M., & Sternberg, C. (2002) · European Urology · doi:10.1016/s0302-2838(01)00026-4 · Cited by 464
Willingness to Pay: A Valid and Reliable Measure of Health State Preference?
O'Brien, B., & Viramontes, J. L. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400311 · Cited by 435
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
Kriegmair, M., Baumgartner, R., Knuchel, R., Stepp, H., Hofstadter, F., & Hofstetter, A. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66559-5 · Cited by 434
Campbell, M., Snowdon, C., Francis, D., Elbourne, D., McDonald, A., Knight, R., Entwistle, V, Garcia, J., Roberts, I., Grant, A., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11480 · Cited by 433
Self-citationBladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Lokeshwar, V. B., Habuchi, T., Grossman, H. B., Murphy, W. M., Hautmann, S. H., Hemstreet, G. P., Bono, A. V., Getzenberg, R. H., Goebell, P., Schmitz-Dräger, B. J., et al. (2005) · Urology · doi:10.1016/j.urology.2005.08.064 · Cited by 431
Oliver, S., Clarke-Jones, L., Rees, R., Milne, R., Buchanan, P., Gabbay, J., Gyte, G., Oakley, A., & Stein, K. (2004) · Health Technology Assessment · doi:10.3310/hta8150 · Cited by 400
Clinical utility of cytokeratins as tumor markers
Barak, V., Goike, H., Panaretakis, K. W., & Einarsson, R. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.009 · Cited by 382
Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies
Brennan, P., Bogillot, O., Cordier, S., Greiser, E., Schill, W., Vineis, P., Lopez-Abente, G., Tzonou, A., Chang-Claude, J., Bolm-Audorff, U., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000415)86:2<289::aid-ijc21>3.0.co;2-m · Cited by 377
Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis
Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D., & Sidransky, D. (1996) · Science · doi:10.1126/science.271.5249.659 · Cited by 376
Churchill, R., Hunot, V., Corney, R., Knapp, M., McGuire, H., Tylee, A., & Wessely, S. (2002) · Health Technology Assessment · doi:10.3310/hta5350 · Cited by 368
Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay
Grossman, H. B. (2005) · JAMA · doi:10.1001/jama.293.7.810 · Cited by 367
Kaltenthaler, E., Brazier, J., De Nigris, E., Tumur, I., Ferriter, M., Beverley, C., Parry, G., Rooney, G., & Sutcliffe, P. (2006) · Health Technology Assessment · doi:10.3310/hta10330 · Cited by 357
Improved Detection of Urothelial Carcinoma In Situ With Hexaminolevulinate Fluorescence Cystoscopy
SCHMIDBAUER, J., WITJES, F., SCHMELLER, N., DONAT, R., SUSANI, M., MARBERGER, M., & MEMBERS OF THE HEXVIX PCB301/01 STUDY GROUP (2004) · Journal of Urology · doi:10.1097/01.ju.0000100480.70769.0e · Cited by 346
JOCHAM, D., WITJES, F., WAGNER, S., ZEYLEMAKER, B., van MOORSELAAR, J., GRIMM, M.-O., MUSCHTER, R., POPKEN, G., KöNIG, F., KNüCHEL, R., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000169257.19841.2a · Cited by 336
COMPARISON OF SCREENING METHODS IN THE DETECTION OF BLADDER CANCER
RAMAKUMAR, S., BHUIYAN, J., BESSE, J. A., ROBERTS, S. G., WOLLAN, P. C., BLUTE, M. L., & O'KANE, D. J. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61899-8 · Cited by 335
Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., CHURCH, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65851-8 · Cited by 331
Fradet, Y., Grossman, H. B., Gomella, L., Lerner, S., Cookson, M., Albala, D., Droller, M. J., & PC B302/01 Study Group (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.028 · Cited by 312
Fluorescence in situ hybridization
Price, C. M. (1993) · Blood Reviews · doi:10.1016/s0268-960x(05)80023-2 · Cited by 302
Pawinski, A., Sylvester, R., Kurth, K. H., Bouffioux, C., Van Der Meijden, A., Parmar, M. K. B., Bijnens, L., For the Members of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group, & The Medical Research Council Working Party on Superficial Bladder Cancer (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65396-5 · Cited by 301
Grossman, H. B., Gomella, L., Fradet, Y., Morales, A., Presti, J., Ritenour, C., Nseyo, U., Droller, M. J., & PC B302/01 Study Group (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.034 · Cited by 300
Elkan, Kendrick, Hewitt, Robinson, Tolley, Blair, Dewey, Williams, & Brummell (2000) · Health Technology Assessment · doi:10.3310/hta4130 · Cited by 297
Sokolova, I. A., Halling, K. C., Jenkins, R. B., Burkhardt, H. M., Meyer, R. G., Seelig, S. A., & King, W. (2000) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60625-3 · Cited by 285
Chan, M. W. Y., Chan, L. W., Tang, N. L. S., TONG, J. H. M., Lo, K. W., Lee, T., Cheung, H. Y., Wong, W. S., Chan, P. S. F., Lai, F. M., et al. (2002) · PubMed · Cited by 282
JICHLINSKI, P., GUILLOU, L., KARLSEN, S. J., MALMSTRÖM, P.-U., JOCHAM, D., BRENNHOVD, B., JOHANSSON, E., GÄRTNER, T., LANGE, N., van den BERGH, H., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000060782.52358.04 · Cited by 278
Denzinger, S., Burger, M., Walter, B., Knuechel, R., Roessler, W., Wieland, W. F., & Filbeck, T. (2007) · Urology · doi:10.1016/j.urology.2006.12.023 · Cited by 274
Tumor Markers in the Diagnosis of Primary Bladder Cancer. A Systematic Review
GLAS, A. S., ROOS, D., DEUTEKOM, M., ZWINDERMAN, A. H., BOSSUYT, P. M. M., & KURTH, K. H. (2003) · Journal of Urology · doi:10.1097/01.ju.0000067461.30468.6d · Cited by 268
Survivin: A promising tumor biomarker
Duffy, M. J., O’Donovan, N., Brennan, D. J., Gallagher, W. M., & Ryan, B. M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.020 · Cited by 267
Kriegmair, M., Ehsan, A., Baumgartner, R., Lumper, W., Knuechel, R., Hofstädter, F., Steinbach, P., & Hofstetter, A. (1994) · Urology · doi:10.1016/s0090-4295(94)80167-3 · Cited by 265
Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay
Grossman, H. B. (2006) · JAMA · doi:10.1001/jama.295.3.299 · Cited by 265
Epidemiology of urinary bladder cancer: from tumor development to patient’s death
Murta-Nascimento, C., Schmitz-Dräger, B. J., Zeegers, M. P., Steineck, G., Kogevinas, M., Real, F. X., & Malats, N. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0168-5 · Cited by 254
Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
Engel, L. S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf018 · Cited by 245
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer
Landman, J., Chang, Y., Kavaler, E., Droller, M. J., & Liu, B. C.-S. (1998) · Urology · doi:10.1016/s0090-4295(98)00219-2 · Cited by 239
Raitanen, M.-P., Aine, R., Rintala, E., Kallio, J., Rajala, P., Juusela, H., & Tammela, T. L. J. (2002) · European Urology · doi:10.1016/s0302-2838(02)00006-4 · Cited by 217
Macaskill, P. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.12.019 · Cited by 210
Diet and Bladder Cancer: A Meta-analysis of Six Dietary Variables
Steinmaus, C. M., Nu ez, S., & Smith, A. H. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010264 · Cited by 210
Kiemeney, L. A. L. M., Witjes, J. A., Heijbroek, R. P., Verbeek, A. L. M., & Debruyne, F. M. J. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35397-1 · Cited by 210
Ting, K. M. (2016) · Encyclopedia of Machine Learning and Data Mining · doi:10.1007/978-1-4899-7502-7_758-1 · Cited by 207
Zaak, D., Kriegmair, M., Stepp, H., Stepp, H., Baumgartner, R., Oberneder, R., Schneede, P., Corvin, S., Frimberger, D., Knüchel, R., et al. (2001) · Urology · doi:10.1016/s0090-4295(00)01053-0 · Cited by 204
DANILTCHENKO, D. I., RIEDL, C. R., SACHS, M. D., KOENIG, F., DAHA, K. L., PFLUEGER, H., LOENING, S. A., & SCHNORR, D. (2005) · Journal of Urology · doi:10.1097/01.ju.0000181814.73466.14 · Cited by 198
Royle, P., & Waugh, N. (2003) · Health Technology Assessment · doi:10.3310/hta7340 · Cited by 194
SHARMA, S., ZIPPE, C. D., PANDRANGI, L., NELSON, D., & AGARWAL, A. (1999) · Journal of Urology · doi:10.1097/00005392-199907000-00014 · Cited by 194
Carcinoma in Situ of the Bladder
Hudson, M. A., & Herr, H. W. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67650-x · Cited by 192
HALLING, K. C., KING, W., SOKOLOVA, I. A., KARNES, R. J., MEYER, R. G., POWELL, E. L., SEBO, T. J., CHEVILLE, J. C., CLAYTON, A. C., KRAJNIK, K. L., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65072-0 · Cited by 188
SHARIAT, S. F., ZIPPE, C., LÜDECKE, G., BOMAN, H., SANCHEZ-CARBAYO, M., CASELLA, R., MIAN, C., FRIEDRICH, M. G., EISSA, S., AKAZA, H., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000154696.48217.75 · Cited by 171
van der Meijden, A., Oosterlinck, W., Brausi, M., Kurth, K.-H., Sylvester, R., deBalincourt, C., & Members of the EORTC-GU Group Superficial Bladder Committee, A. (1999) · European Urology · doi:10.1159/000019859 · Cited by 168
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use
Morgan, K., Dixon, S., Mathers, N., Thompson, J., & Tomeny, M. (2004) · Health Technology Assessment · doi:10.3310/hta8080 · Cited by 166
Filbeck, T., Pichlmeier, U., Knuechel, R., Wieland, W. F., & Roessler, W. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64833-1 · Cited by 162
Hungerhuber, E., Stepp, H., Kriegmair, M., Stief, C., Hofstetter, A., Hartmann, A., Knuechel, R., Karl, A., Tritschler, S., & Zaak, D. (2007) · Urology · doi:10.1016/j.urology.2006.10.015 · Cited by 158
RIEDL, C. R., Daniltchenko, D. I., Koenig, F., Simak, R., Loening, S. A., & Pflueger, H. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66442-7 · Cited by 155
Rodgers, M., NIXON, J. P., Hempel, S., Aho, T., Kelly, J. D., Neal, D. E., Duffy, S., Ritchie, G., Kleijnen, J., & Westwood, M. E. (2006) · Health Technology Assessment · doi:10.3310/hta10180 · Cited by 151
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 146
Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
Kinoshita, H., Ogawa, O., Kakehi, Y., Mishina, M., Itoh, N., Yamada, H., Terachi, T., & Yoshida, O. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.724 · Cited by 141
Babjuk, M. M., Soukup, V., Petrík, R., Jirsa, M., & Dvořáček, J. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.05715.x · Cited by 133
Issues in methodological research: perspectives from researchers and commissioners
Lilford, R. J., Richardson, A., Stevens, A., Fitzpatrick, R., Edwards, S., Rock, F., & Hutton, J. L. (2001) · Health Technology Assessment · doi:10.3310/hta5080 · Cited by 132
Kriegmair, M., Zaak, D., Rothenberger, K.-H., Rassweiler, J. J., Jocham, D., EISENBERGER, F., Tauber, R., Stenzl, A., & Hofstetter, A. G. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64661-7 · Cited by 130
Jichlinski, P., Forrer, M., Mizeret, J. C., Glanzmann, T. M., Braichotte, D. R., Wagnières, G., Zimmer, G., Guillou, L., Schmidlin, F. R., Graber, P., et al. (1997) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1997)20:4<402::aid-lsm5>3.0.co;2-u · Cited by 130
Koenig, F., McGovern, F. J., Larne, R., Enquist, H., Schomacker, K. T., & Deutsch, T. F. (1999) · BJU International · doi:10.1046/j.1464-410x.1999.00917.x · Cited by 129
MARTI, A., JICHLINSKI, P., LANGE, N., BALLINI, J.-P., GUILLOU, L., LEISINGER, H. J., & KUCERA, P. (2003) · Journal of Urology · doi:10.1097/01.ju.0000075054.38441.2d · Cited by 129
Role of 5‐aminolevulinic acid in the detection of urothelial premalignant lesions
Zaak, D., Hungerhuber, E., Schneede, P., Stepp, H. G., Frimberger, D. C., Corvin, S., Schmeller, N., Kriegmair, M., Hofstetter, A. G., & Knöchel, R. (2002) · Cancer · doi:10.1002/cncr.10821 · Cited by 126
Kipp, B. R., Karnes, R. J., Brankley, S. M., Harwood, A. R., Pankratz, V. S., Sebo, T. J., BLUTE, M. M., Lieber, M. M., Zincke, H., & Halling, K. C. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000149825.83180.a4 · Cited by 120
Should we screen for bladder cancer in a high‐risk population? A cost per life‐year saved analysis
Lotan, Y., Svatek, R. S., & Sagalowsky, A. I. (2006) · Cancer · doi:10.1002/cncr.22084 · Cited by 118
A study comparing various noninvasive methods of detecting bladder cancer in urine
Saad, A., Hanbury, D. C., McNicholas, T., Boustead, G. B., Morgan, S., & Woodman, A. (2002) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.01699.x · Cited by 117
Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer
Sanchini, M. A. (2005) · JAMA · doi:10.1001/jama.294.16.2052 · Cited by 112
Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy
Zaak, D., Karl, A., Knüchel, R., Stepp, H. G., Hartmann, A., Reich, O. M., Bachmann, A., Siebels, M., Popken, G., & Stief, C. G. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05604.x · Cited by 111
Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients
Herr, H. W. (1997) · World Journal of Urology · doi:10.1007/bf02201977 · Cited by 110
The contribution of cigarette smoking to bladder cancer in women (pooled European data)
Brennan, P., Bogillot, O., Greiser, E. M., Chang-Claude, J. C., Wahrendorf, J., Cordier, S., Jöckel, K., López‐Abente, G., Τζώνου, Α., Vineis, P., et al. (2001) · Cancer Causes & Control · doi:10.1023/a:1011214222810 · Cited by 109
Rieger‐Christ, K., Mourtzinos, A. P., Lee, P. J., Zagha, R. M., Cain, J. E., Silverman, M. L., Libertino, J. A., & Summerhayes, I. C. (2003) · Cancer · doi:10.1002/cncr.11536 · Cited by 109
Burger, M., Zaak, D., Stief, C. G., Filbeck, T., Wieland, W. F., Roessler, W., & Denzinger, S. (2007) · European Urology · doi:10.1016/j.eururo.2007.01.064 · Cited by 107
NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER
Zippe, C. D., PANDRANGI, L., & Agarwal, A. K. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)62063-9 · Cited by 107
Têtu, B., Tiguert, R., Harel, F., & Fradet, Y. (2004) · Modern Pathology · doi:10.1038/modpathol.3800262 · Cited by 101
HAUTMANN, S. H., Toma, M. I., Gómez, M. F., Friedrich, M. G., Jäkel, T., Michl, U. H. G., Schroeder, G. L., Huland, H., Juenemann, K., & Lokeshwar, V. B. (2004) · European Urology · doi:10.1016/j.eururo.2004.06.006 · Cited by 94
Loidl, W., Schmidbauer, J., Susani, M., & Marberger, M. (2004) · European Urology · doi:10.1016/j.eururo.2004.10.025 · Cited by 90
Grimbergen, M. C. M., van Swol, C. F. P., Jonges, T. G. N., Boon, T. A., & van Moorselaar, R. J. A. (2003) · European Urology · doi:10.1016/s0302-2838(03)00210-0 · Cited by 90
Filbeck, T., Roessler, W., Knuechel, R., Straub, M., Kiel, H. J., & Wieland, W. F. (1999) · Journal of Endourology · doi:10.1089/end.1999.13.117 · Cited by 89
Giannopoulos, A., MANOUSAKAS, T., GOUNARI, A., et al. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65965-4 · Cited by 85
Witjes, J. A., Moonen, P. M. J., & van der Heijden, A. G. (2004) · European Urology · doi:10.1016/j.eururo.2004.09.017 · Cited by 79
Filbeck, T., Roessler, W., Knuechel, R., Straub, M., Kiel, H. J., & Wieland, W. F. (1999) · Urology · doi:10.1016/s0090-4295(98)00430-0 · Cited by 77
zen, S. S., Biri, H., k, Z. S. I. N. I., et al. (1999) · European Urology · doi:10.1159/000068002 · Cited by 70
Friedrich, M. G., Toma, M. I., Hellstern, A., et al. (2003) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04528.x · Cited by 70
The economics of cancer care in the UK
Bosanquet, N., & Sikora, K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01569-4 · Cited by 66
Weikart, L. A., Chen, G. G., & Sermier, E. (2013) · CQ Press eBooks · doi:10.4135/9781544306841.n4 · Cited by 65
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee, D. H., Yang, S. C., Hong, S. J., Chung, B. H., & Kim, I. Y. (1998) · PubMed · Cited by 64
Kriegmair, M., Stepp, H. G., Steinbach, P., Lumper, W., Ehsan, A., Stepp, H. G., Rick, K., Knüchel, R., Baumgärtner, R., & Hofstetter, A. G. (2010) · Urologia Internationalis · doi:10.1159/000282784 · Cited by 62
Dalbagni, G. M., Han, W., Zhang, Z., Cordon‐Cardo, C., Saigo, P. E., Fair, W. R., Herr, H. W., Kim, N., & Moore, M. A. S. (1997) · PubMed · Cited by 60
Miyanaga, N., Akaza, H., Tsukamoto, T., et al. (1999) · International Journal of Urology · doi:10.1046/j.1442-2042.1999.06437.x · Cited by 59
Survivin: Role in Diagnosis, Prognosis, and Treatment of Bladder Cancer
Akhtar, M., Gallagher, L., & Rohan, S. M. (2006) · Advances in Anatomic Pathology · doi:10.1097/00125480-200605000-00003 · Cited by 55
Kriegmair, M., Zaak, D., Stepp, H., Stepp, H. G., Baumgartner, R., Knuechel, R., & Hofstetter, A. G. (1999) · European Urology · doi:10.1159/000020019 · Cited by 53
Usefulness of the BTA stat Test for the diagnosis of bladder cancer
Baños, J. L. G., Rodrigo, M. D. H. R., Juárez, F. M. A., & García, B. M. (2001) · Urology · doi:10.1016/s0090-4295(00)01090-6 · Cited by 52
Fluorescence Detection of Bladder Tumors with 5-Amino-Levulinic Acid
RIEDL, C. R., Plas, E., & Pflüger, H. (1999) · Journal of Endourology · doi:10.1089/end.1999.13.755 · Cited by 51
Schneeweiß, S., Kriegmair, M., & Stepp, H. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61605-7 · Cited by 51
Garbar, C., Mascaux, C., & Wespes, E. (2007) · Cytopathology · doi:10.1111/j.1365-2303.2007.00426.x · Cited by 49
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. F. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-4 · Cited by 49
YOKOTA, K., Kanda, K., Inoue, Y., Kanayama, H., & Kagawa, S. (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00827.x · Cited by 47
Parekattil, S. J., Fisher, H. A. �., & Kogan, B. A. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000051322.60266.06 · Cited by 45
Dominicis, C. D., Liberti, M., Perugia, G., Nunzio, C. D., Sciobica, F., Zuccalà, A., Sárközy, A., & Iori, F. (2001) · Urology · doi:10.1016/s0090-4295(01)00948-7 · Cited by 44
Weikert, S., Krause, H., Wolff, I., Christoph, F., Schrader, M. G., Emrich, T., Miller, K., & Müller, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21168 · Cited by 43
Schelling, T. C. (1989) · Social Economics · doi:10.1007/978-1-349-19806-1_34 · Cited by 40
Casella, R., Huber, P., Blöchlinger, A., et al. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)66920-0 · Cited by 39
Sharkey, F. E., & Sarosdy, M. F. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65282-0 · Cited by 38
Neves, M., Ciofu, C., Larousserie, F., Fleury‐Feith, J., Sibony, M., Flahault, A., Soubrier, F., & Gattegno, B. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65281-0 · Cited by 38
D’Hallewin, M., Vanherzeele, H. A., & Baert, L. V. (1998) · American Journal of Clinical Oncology · doi:10.1097/00000421-199806000-00002 · Cited by 38
Zhang, F. F., Arber, D. A., Wilson, T. G., Kawachi, M. H., & Slovak, M. L. (1997) · PubMed · Cited by 38
Shariat, S. F., Matsumoto, K., Casella, R., Jian, W., & Lerner, S. P. (2005) · European Urology · doi:10.1016/j.eururo.2005.02.012 · Cited by 34
Eissa, S., Labib, R. A., Mourad, S., Kamel, K. M., & El-Ahmady, O. (2003) · European Urology · doi:10.1016/s0302-2838(03)00417-2 · Cited by 34
Abbate, I., D’Introno, A., Cardo, G., et al. (1999) · PubMed · Cited by 34
Raitanen, M., Leppilahti, M., Tuhkanen, K., et al. (2001) · PubMed · Cited by 31
Bialkowska-Hobrzanska, H., Bowles, L., Bukala, B., Joseph, M. G., Fletcher, R., & RAZVI, H. A. (2000) · PubMed · doi:10.1007/bf03262087 · Cited by 31
5-Aminolevulinic Acid-Induced Fluorescence Endoscopy for the Detection of Lower Urinary Tract Tumors
Kriegmair, M., Zaak, D., Knuechel, R., Baumgartner, R., & Hofstetter, A. G. (1999) · Urologia Internationalis · doi:10.1159/000030415 · Cited by 30
Lahme, S., Bichler, K., Feil, G., et al. (2001) · Urologia Internationalis · doi:10.1159/000056574 · Cited by 29
Bass, R. A., Hemstreet, G. P., Honker, N. A., Hurst, R. E., & Doggett, R. S. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400522 · Cited by 29
Chahal, R., Darshane, A., Browning, A., et al. (2001) · European Urology · doi:10.1159/000049809 · Cited by 26
Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology.
Khalbuss, W. E., & Goodison, S. (2006) · CytoJournal · doi:10.1186/1742-6413-3-18 · Cited by 26
Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients.
Morsi, M. I., Youssef, A. I., Hassouna, M. E., El-Sedafi, A. S., Ghazal, A. A. E. R., & Zaher, E. R. (2006) · PubMed · Cited by 23
Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer
Öge, Ö., Atsü, N., Kendi̇, S., et al. (2001) · International Urology and Nephrology · doi:10.1023/a:1017509418440 · Cited by 22
Free DNA in Urine: A New Marker for Bladder Cancer? Preliminary Data
Zancan, M., FRANCESCHINI, R., Mimmo, C., Vianello, M., Tonno, F. D., Mazzariol, C., MALOSSINI, G., & Gion, M. (2005) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.5367 · Cited by 22
Raitanen, M., m, P. H. O., Marttila, T. I., Korhonen, H., Talja, M. T., Ervasti, J., & Tammela, T. L. J. (2001) · European Urology · doi:10.1159/000049810 · Cited by 21
Jichlinski, P., Wagnières, G., Forrer, M., Mizeret, J. C., Guillou, L., Oswald, M., Schmidlin, F. R., Graber, P., van den Bergh, H., & Leisinger, H. (1997) · Urological Research · doi:10.1007/bf00942040 · Cited by 20
Fluorescence cystoscopy: is it ready for use in routine clinical practice?
Spiess, P. E., & Grossman, H. B. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000240312.16324.9a · Cited by 19
Fluorescence cytology of the urinary bladder
Tauber, S., Schneede, P., Liedl, B., Ließmann, F., Zaak, D., & Hofstetter, A. G. (2003) · Urology · doi:10.1016/s0090-4295(02)02554-2 · Cited by 19
The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer
Jain, S., & Kockelbergh, R. C. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.05559.x · Cited by 18
Fluorescence detection of bladder carcinoma
Koenig, F., & McGovern, F. J. (1997) · Urology · doi:10.1016/s0090-4295(97)00409-3 · Cited by 18
Paoluzzi, M., Mg, C., Mugnaini, P., et al. (1999) · PubMed · Cited by 18
Cheng, C., Lau, W. K. O., Tan, P. H., & Olivo, M. (2000) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v29n2p153 · Cited by 17
Ehsan, A., Sommer, F. O., Haupt, G., & Engelmann, U. H. (2001) · Urologia Internationalis · doi:10.1159/000051007 · Cited by 17
Diagnostic Efficacy of Fluorescence Cystoscopy for Detection of Urothelial Neoplasms
Jeon, S. S., Kang, I., Hong, J. H., Choi, H. Y., & Chai, S. E. (2001) · Journal of Endourology · doi:10.1089/08927790152596370 · Cited by 16
Lee, K. H. (2001) · Yonsei Medical Journal · doi:10.3349/ymj.2001.42.1.14 · Cited by 13
Detection of bladder dysplasia using 5‐aminolaevulinic acid‐induced porphyrin fluorescence
Landry, J. L., Gelet, A., Bouvier, R., Dubernard, J. M., Martin, X. S., & Colombel, M. C. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04182.x · Cited by 12
Schneeweiß, S. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300102107 · Cited by 8
Collaud, S., Jichlinski, P., Martí, A., Aymon, D., Gurny, R., & Lange, N. (2006) · Drugs in R&D · doi:10.2165/00126839-200607030-00005 · Cited by 8
Song, X., Ye, Z., Zhou, S., Yang, W., Zhang, X., Liu, J., & Ma, Y. (2007) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2006.12.001 · Cited by 6
Cited by
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Böhle, A., Palou-Redorta, J., & Rouprêt, M. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.017 · Cited by 1,067
Avery, K. N. L., Williamson, P. R., Gamble, C., O'Connell Francischetto, E., Metcalfe, C., Davidson, P., Williams, H., & Blazeby, J. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013537 · Cited by 575
What can qualitative research do for randomised controlled trials? A systematic mapping review
O'Cathain, A., Thomas, K. J., Drabble, S. J., Rudolph, A., & Hewison, J. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002889 · Cited by 438
Kamat, A. M., Hegarty, P. K., Gee, J. R., Clark, P. E., Svatek, R. S., Hegarty, N., Shariat, S. F., Xylinas, E., Schmitz-Dräger, B. J., Lotan, Y., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.09.057 · Cited by 263
Empirical evidence of the importance of comparative studies of diagnostic test accuracy
Takwoingi, Y., Leeflang, M. M. G., & Deeks, J. J. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-7-201304020-00006 · Cited by 187
Metadata
- Authors
- Mowatt, G., Zhu, S., Kilonzo, M., Boachie, C., Fraser, C., Griffiths, T., N'Dow, J., Nabi, G., Cook, J., & Vale, L.
- Venue
- Health Technology Assessment
- Published
- 2010-01
- Volume
- 14
- Issue
- 4
- Pages
- 1-331, iii
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1964561132
- Cited by
- 313
- References
- 160
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.